Why the study?
Do MIB-1 index and tumour size predict metastatic disease in patients with primary synovial sarcoma?
Population
86 patients with primary synovial sarcoma located in the extremities or on the trunk wall, from the…
Design
Cohort
Follow-up
5 years
Authors
Loading...
May stratify metastatic risk in synovial sarcoma; extends prognostic factors but leaves open impact on adjuvant decisions.
Do MIB-1 index and tumour size predict metastatic disease in patients with primary synovial sarcoma?
MIB-1 index combined with tumor size strongly predicts metastatic risk in synovial sarcoma, helping identify candidates for adjuvant chemotherapy.
Skytting et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: